BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Clinical Outcome
13 results:

  • 1. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
    Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
    Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.
    Brøndum L; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Evensen JF; Kristensen CA; Andersen LJ; Overgaard J; Eriksen JG
    Acta Oncol; 2018 Sep; 57(9):1159-1164. PubMed ID: 29771169
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Influence of apoptosis (BCL2, FAS), cell cycle (ccnd1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer.
    Jain M; Kumar S; Upadhyay R; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Biol Ther; 2007 Oct; 6(10):1553-8. PubMed ID: 17912028
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
    Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
    Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cyclin D1 gene (ccnd1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
    Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
    Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Inactivation of p53 and amplification of cyclin D1 in squamous cell carcinomas of the head and neck].
    Rodrigo Tapia JP; González Meana MV; García González LA; Coto E; García Pedrero J; Núñez Batalla F; Suárez Nieto C
    Acta Otorrinolaringol Esp; 2002 Apr; 53(4):225-32. PubMed ID: 12185899
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
    Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
    Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
    Watanabe M; Kuwano H; Tanaka S; Toh Y; Sadanaga N; Sugimachi K
    Cancer; 1999 Jun; 85(11):2322-8. PubMed ID: 10357400
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
    Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
    Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
    Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
    Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.